Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study

Overview of attention for article published in Frontiers in Neuroscience, March 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 76,518 followers.

RT @FrontNeurosci: New Research: Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo stud…

01 Apr 2023

Reply Repost Favourite

New Research: Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study: Introduction In type 2 diabetes mellitus (T2DM), the antidiuretic system participates in the adaptation to osmotic… https://t.co/waT

01 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.